New drug duo aims to stop aggressive liver Cancer's return
NCT ID NCT07243951
Summary
This study is testing whether a combination of two drugs can help prevent a rare and aggressive type of liver cancer from returning after surgery. About 75 patients who have had their tumor removed but are at medium to high risk of it coming back will receive both an immunotherapy drug (given by IV) and a chemotherapy pill. The main goal is to see if this treatment helps patients live longer without the cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.